Skip to content
OpenCapital
Get started

Inspire Medical Systems INSP EPS (Diluted)

EPS (Diluted) at other companies

LivaNova logo
LivaNovaLIVN
$0.40+107%
Stryker logo
StrykerSYK
$1.93+14.2%
ITG
Integer HoldingsITGR
$0.48+173%
Medtronic logo
MedtronicMDT
$0.97+18.3%
Intuitive Surgical logo
Intuitive SurgicalISRG
$2.28+18.7%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-68.7%
Enterprise value$1.18B-70.0%
P/E9.5×-50.2×
P/S1.4×-3.4×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0×0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's EPS (diluted)?
Inspire Medical Systems (INSP) reported EPS (diluted) of -$0.39 in Q1 2026.
How has Inspire Medical Systems's EPS (diluted) changed year-over-year?
Inspire Medical Systems's EPS (diluted) decreased by 490.0% year-over-year, from $0.10 to -$0.39.
What is the long-term trend for Inspire Medical Systems's EPS (diluted)?
Over 3 years (2021 to 2025), Inspire Medical Systems's EPS (diluted) has grown at a 47.1% compound annual growth rate (CAGR), from -$1.54 to $4.90.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.